China's State Council issued a series of new pandemic control measures on December 7, relaxing restrictions on travel and boosting the search volume on domestic ticketing platforms.
The "false negative COVID results" of Lanzhou Nucleus Gene Huaxi pulled by the Shenzhen-based nucleic acid testing company and its actual controller Zhang Hezi from behind the scenes to the front and center.
With Hainan being a popular tourist destination in China, many domestic tourist platforms showed that orders of air tickets and hotels soared after the province adjusted its pandemic prevention and control measures.
The Omicron COVID-19 variant, which appears more transmissible but less pathogenic than earlier strains of the coronavirus, has caused a surge in demand for nucleic acid testing in China this year. However, false positives have frequently been reported.
Many local authorities in China have successively issued new pandemic prevention measures in the last two days, reducing the frequency of nucleic acid testing and advocating for more antigen tests. This has triggered an increase in demand among Chinese consumers for antigen test kits, and resources are now in short supply.
Recently, Chinese nucleic acid testing companies have been controversial and accused of making huge profits during the COVID-19 pandemic. Among them, a company called Nucleus Gene has aroused widespread public doubts.
William Li, the co-founder and CEO of Chinese electric vehicle firm NIO, offered insight regarding user experience, supply chains, production capacity, and recent progress of the firm's mobile phone business.
Foxconn, Apple's largest iPhone foundry, said on November 7 that it is working hard to resume full production at its Zhengzhou factory as soon as possible, and lowered its fourth-quarter performance forecast.
Foxconn, the Taiwan-based leading iPhone assembler, issued a statement at midday on October 26 saying that "reports of 20,000 people diagnosed with COVID-19 at the Zhengzhou Industrial Park, Henan Province" circulating online were "seriously false information."
In response to rumors that "Bianlifeng sees wave of store closures", the Chinese convenience store chain startup told the domestic media on August 16: "There is no tide of store closures. The stores affected by the pandemic are gradually resuming business."
MenuSifu, a point of sale (POS) software developer, on July 27 announced it had closed a $20 million Series B fundraising round, led by Challenjers Venture.
Major digital platforms offering daily services to Shanghai residents have also adopted measures to support the efforts, including Meituan Waimai and DiDi Global Inc.
In this op-ed, tuzhuxi argues that Hong Kong lacks the necessary political, social and cultural foundations to execute the “Dynamic Zero-Covid” strategy, and meanwhile it dares not perform the “lying flat” policy to coexist with the virus.
Gotin, an online activity platform, recently completed a Pre-A round of financing. This round of funding was led by GL Ventures and followed by MSA Capital, Jinshajiang Venture Capital, and Picus.
As its three-month internal stress test draws to a close, the Universal Beijing Resort (UBR) announced on Tuesday it will officially start trial operations on September 1.
From contact tracing systems to driverless food delivery and medical supply vehicles, AI technology has been used in more daily life scenarios during the Covid-19 pandemic in China.
DiDi released a “2020 in Numbers” report on Thursday to capture the firm’s highlights from last year, with the pandemic in 2020 bringing the firm new opportunities and challenges.
China’s robotics industry saw rapid growth this year. According to a report released by Buy Shares, there were 381,000 units of industrial robots globally as of September 2020.